Micropulse laser for central serous chorioretinopathy (RCS / CCS)When fluid accumulates under the centre of the retina.
Central serous retinopathy (RCS), often called central serous chorioretinopathy (CCS) in medical publications, mainly affects the macula and choroid. Fluid collects beneath the retina and may cause blurred vision, distorted lines, a grey patch in the visual field, changes in the perceived size of objects or reduced contrast vision.
Many acute cases resolve on their own within a few months. If fluid persists, returns or threatens lasting damage to the pigment epithelium and photoreceptors, we assess treatment options using OCT and, where needed, fluorescein and ICG angiography.
How the micropulse laser works
Brief pulses alternate with cooling intervals. Unlike conventional visible laser coagulation, no permanent retinal scar is intended. Treatment targets carefully mapped leakage or fluid areas.
Who may benefit
Treatment may help selected persistent or recurrent cases, particularly when the imaging and leakage site fit the procedure. Acute central serous retinopathy is not automatically treated with laser straight away.
What are the alternatives?
Depending on the findings, options include observation, conventional focal laser treatment outside the fovea or photodynamic therapy. In the PLACE study of chronic central serous retinopathy, half-dose photodynamic therapy was more effective overall than the micropulse procedure studied.
What we check afterwards
Visual acuity, symptoms and fluid on OCT guide the assessment. The effect develops over time; persistent fluid may require repeat or alternative treatment.